Alexandre Tisserand
Investment Manager
Realized
Clario
Clario delivers leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 FDA drug approvals, Clario fuses nearly 50 years of scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives.
Overview
Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 offices in nine countries across North America, Europe and Asia Pacific, Clario’s global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years.
Head office
Headquartered in Philadelphia (US), the company employs ca. 3,800 people globally.
Global sales
Clario supports trials in 120+ countries and ships over 100,000 devices per year
Healthcare sector2020 Entry into PortfolioFund Astorg VII4000 EMPLOYEESHealthcare sector2020 Entry into PortfolioFund Astorg VII4000 EMPLOYEESHealthcare sector2020 Entry into PortfolioFund Astorg VII4000 EMPLOYEESHealthcare sector2020 Entry into PortfolioFund Astorg VII4000 EMPLOYEES
Meet the team behind our deep
expertise and market-leading results
Antoine Thomas
Director
François de Mitry
Partner, Chair of the Investment Committees
Judith Charpentier
Co-Managing Partner and Co-Head Flagship
Olivier Lieven
Partner, Healthcare Flagship
